Generics and Biosimilars in Central and Eastern Europe

A session at Generics and Biosimilars in Central and Eastern Europe


Focusing on opportunities and challenges, senior directors, partners and board members will discuss trends in generic and biosimilar development, manufacturing and commercialisation.


Attend to benefit from:

A detailed overview of the generics and biosimilars landscape in CEE, including a macro-economic outlook on the region: Pinpoint key trends in the hottest markets – Poland, Slovakia and Ukraine.

Useful insights into the complex legal and regulatory framework: Ensure your company is fully prepared to tackle upcoming changes.

Learning about various partnering strategies, their benefits and ground-breaking examples of effective International co-operation.

An excellent opportunity for international companies to learn how to access the market in CEE and be commercially successful.

A review of differentiation strategies for generics, focusing on super generics.


Booking: http://atnd.it/10gRJ7G

Price: €1413.27

Keywords: biosimilars, generics, europe.

Artists / Speakers: Vladimir Zah, Nicola Travierso, Agnieszka Skonieczna, Natalia Salamova, Federico Pollano, Iris Margraf, Alex Kudrin, Oleksandr Kryuk, Ranjith Gopinathan, Milosz Gruca, Klaus Martin, Rok Hren, Vojtěch Mészáros, Alan Sheppard.

Sign in to add slides, notes or videos to this session

Tell your friends!


Date Tue 25th June 2013

Short URL


Official event site


View the schedule


See something wrong?

Report an issue with this session